RLYB Logo

Rallybio Corporation (RLYB) 

NASDAQ
Market Cap
$58.03M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
734 of 809
Rank in Industry
403 of 445

Largest Insider Buys in Sector

RLYB Stock Price History Chart

RLYB Stock Performance

About Rallybio Corporation

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; and RLYB116, a subcutaneously administered inhibitor of C5 for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.

Insider Activity of Rallybio Corporation

Over the last 12 months, insiders at Rallybio Corporation have bought $0 and sold $0 worth of Rallybio Corporation stock.

On average, over the past 5 years, insiders at Rallybio Corporation have bought $19.67M and sold $5.24M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $26,050 was made by Lieber Jonathan I () on 2023‑03‑14.

List of Insider Buy and Sell Transactions, Rallybio Corporation

2023-03-14PurchaseLieber Jonathan I
5,000
0.0123%
$5.21$26,050-13.69%
2023-03-07SalePARMAR KUSHdirector
100,000
0.242%
$8.20$820,000-44.54%
2023-03-07Sale5AM Partners V, LLC10 percent owner
100,000
0.242%
$8.20$820,000-44.54%
2022-06-03SaleROCKLAGE SCOTT M
99,671
0.4398%
$12.50$1.25M-23.70%
2022-06-03SalePARMAR KUSH
99,671
0.4398%
$12.50$1.25M-23.70%
2022-05-23SaleROCKLAGE SCOTT M
33,553
0.1126%
$13.00$436,189-43.36%
2022-05-23SalePARMAR KUSH
33,553
0.1126%
$13.00$436,189-43.36%
2022-03-21PurchaseFryer Jeffrey MSee Remarks
3,000
0.0103%
$8.04$24,120+4.79%
2022-02-08SalePARMAR KUSHdirector
210,000
0.6366%
$13.05$2.74M-36.62%
2022-02-08Sale5AM Opportunities I, L.P.10 percent owner
210,000
0.6366%
$13.05$2.74M-36.62%
2022-01-19PurchaseFryer Jeffrey MSee Remarks
1,400
0.0046%
$8.70$12,180+7.49%
2022-01-13PurchaseUden StephenSee Remarks
5,000
0.0172%
$9.15$45,752+6.63%
2022-01-12PurchaseUden StephenSee Remarks
5,000
0.0176%
$10.55$52,750-5.66%
2022-01-11PurchaseMACKAY MARTINChief Executive Officer
4,496
0.0146%
$10.65$47,882-13.16%
2022-01-10PurchaseMACKAY MARTINChief Executive Officer
5,504
0.0172%
$10.10$55,590-11.65%
2022-01-07PurchaseFryer Jeffrey MSee Remarks
10,000
0.0313%
$9.41$94,069-4.69%
2021-08-02PurchaseSHANNON TIMOTHY Mdirector
76,923
0.2018%
$13.00$999,999-39.61%
2021-08-02PurchaseHUNT RONALDdirector
307,692
0.8073%
$13.00$4M-39.61%
2021-08-02PurchaseHopfner Robert Lornedirector
576,923
1.5136%
$13.00$7.5M-39.61%
2021-08-02PurchasePARMAR KUSHdirector
615,384
1.6145%
$13.00$8M-39.61%

Insider Historical Profitability

<0.0001%
VIKING GLOBAL INVESTORS LP10 percent owner
4194777
11.0991%
$1.4010<0.0001%
ROCKLAGE SCOTT M
2478969
6.5592%
$1.4002
SHANNON TIMOTHY Mdirector
2409712
6.376%
$1.4010<0.0001%
PARMAR KUSHdirector
2378969
6.2946%
$1.4014<0.0001%
5AM Partners V, LLC10 percent owner
2378969
6.2946%
$1.4001
HUNT RONALDdirector
2301603
6.0899%
$1.4010<0.0001%
Hopfner Robert Lornedirector
2267411
5.9994%
$1.4010<0.0001%
5AM Opportunities I, L.P.10 percent owner
1335637
3.534%
$1.4011<0.0001%
Uden StephenSee Remarks
719127
1.9028%
$1.4020+0.48%
MACKAY MARTINChief Executive Officer
282609
0.7478%
$1.4020<0.0001%
Fryer Jeffrey MSee Remarks
47048
0.1245%
$1.4030+2.53%
Lieber Jonathan I
5000
0.0132%
$1.4010<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Viking Global Investors$7.76M10.124.19M0%+$0<0.01
5Am Venture Management Llc$6.72M8.763.63M0%+$00.45
New Leaf Venture Partners$6.11M7.973.3M0%+$05.35
Tpg Gp A Llc$5.6M7.313.03M0%+$00.11
Pivotal Bioventure Partners Investment Advisor Llc$4.45M5.82.4M0%+$03.26
Fidelity Investments$4.22M5.52.28M-10.09%-$473,513.13<0.0001
Canaan Partners Xi Llc$3.81M4.972.06M0%+$04.2
Standard Life$3.2M4.171.73M0%+$00.01
BlackRock$3.1M4.041.68M-4.54%-$147,311.80<0.0001
The Vanguard Group$1.99M2.61.08M+1.2%+$23,681.86<0.0001
Laurion Capital Management LP$1.45M1.89783,3910%+$00.04
Geode Capital Management$961,438.001.25519,648+2.85%+$26,618.42<0.0001
State Street$950,378.001.24513,718+1.01%+$9,523.80<0.0001
Renaissance Technologies$903,000.001.18488,100New+$903,000.00<0.01
Mariner Llc$750,417.000.98405,631+0.24%+$1,805.60<0.01
Citadel Advisors LLC$739,375.000.96399,662+25.5%+$150,220.06<0.0001
Blue Owl Capital Holdings Lp$647,944.000.85350,2400%+$00.12
Northern Trust$452,815.000.59244,765-2.01%-$9,292.55<0.0001
Millennium Management LLC$364,041.000.48196,779+453.2%+$298,234.68<0.0001
Bridgeway Capital Management$177,970.000.2396,200-25.14%-$59,755.00<0.01
BNY Mellon$167,084.000.2290,316+0.04%+$70.30<0.0001
Charles Schwab$142,483.000.1977,0180%+$0<0.0001
Morgan Stanley$141,306.000.1876,382-22.94%-$42,063.24<0.0001
Nuveen$118,121.000.1563,8490%+$0<0.0001
RhumbLine Advisers$73,907.000.139,954+3.08%+$2,210.51<0.0001
Barclays$68,000.000.0937,020-35.59%-$37,580.01<0.0001
Squarepoint Ops LLC$67,386.000.0936,425+159.51%+$41,419.50<0.0001
Acadian Asset Management$57,000.000.0831,294New+$57,000.00<0.0001
UBS$56,745.000.0730,673+19.2%+$9,140.84<0.0001
Marshall Wace$53,710.000.0729,032+93.22%+$25,913.34<0.0001
Wells Fargo$48,128.000.0626,015+170.17%+$30,314.26<0.0001
Bank of America$44,251.000.0623,919-60.93%-$69,019.28<0.0001
Xtx Topco Ltd$42,163.000.0622,791New+$42,163.00<0.01
NORTHEAST FINANCIAL CONSULTANTS, INC$40,863.000.0522,088New+$40,863.00<0.01
HarbourVest Partners$40,472.000.0521,8770%+$00.02
Dimensional Fund Advisors$39,226.000.0521,203-28.47%-$15,614.18<0.0001
American International Group$27,874.000.0415,067-0.85%-$240.50<0.0001
Susquehanna International Group$26,988.000.0414,588+27.77%+$5,866.39<0.0001
JPMorgan Chase$26,995.000.0414,592-26.94%-$9,952.93<0.0001
Goldman Sachs$24,500.000.0313,243-30.37%-$10,683.95<0.0001
Utah Retirement Systems$24,494.000.0313,2400%+$0<0.0001
Capstone Investment Advisors$20,165.000.0310,900+9%+$1,665.00<0.01
SG Americas Securities, LLC$20,000.000.0310,565-37.16%-$11,827.73<0.0001
New York State Common Retirement Fund$19,000.000.0310,4670%+$0<0.0001
CAPTRUST$18,557.000.0210,031New+$18,557.00<0.0001
Mercer Global Advisors Inc Adv$19,000.000.0210,000New+$19,000.00<0.0001
Tower Research Capital$15,020.000.028,119+118.9%+$8,158.42<0.0001
Citigroup$11,744.000.026,348-53.43%-$13,473.78<0.0001
Russell Investments Group Ltd$7,483.000.014,045New+$7,483.00<0.0001
CalSTRS$6,423.000.013,472-31%-$2,885.91<0.0001